{"count":47031,"next":"http://search-api.het.io/v1/nodes/?format=json&limit=25&offset=7575","previous":"http://search-api.het.io/v1/nodes/?format=json&limit=25&offset=7525","results":[{"id":7541,"identifier":"GO:1900273","identifier_type":"str","name":"positive regulation of long-term synaptic potentiation","properties":{"url":"http://purl.obolibrary.org/obo/GO_1900273","source":"Gene Ontology","license":"CC BY 4.0"},"metanode":"Biological Process"},{"id":7542,"identifier":"6139","identifier_type":"int","name":"RPL17","properties":{"url":"http://identifiers.org/ncbigene/6139","source":"Entrez Gene","license":"CC0 1.0","chromosome":"18","description":"ribosomal protein L17"},"metanode":"Gene"},{"id":7543,"identifier":"10550","identifier_type":"int","name":"ARL6IP5","properties":{"url":"http://identifiers.org/ncbigene/10550","source":"Entrez Gene","license":"CC0 1.0","chromosome":"3","description":"ADP-ribosylation factor-like 6 interacting protein 5"},"metanode":"Gene"},{"id":7544,"identifier":"C0541766","identifier_type":"str","name":"Aggravation of existing disorder","properties":{"url":"http://identifiers.org/umls/C0541766","source":"UMLS via SIDER 4.1","license":"CC BY-NC-SA 4.0"},"metanode":"Side Effect"},{"id":7545,"identifier":"GO:0030210","identifier_type":"str","name":"heparin biosynthetic process","properties":{"url":"http://purl.obolibrary.org/obo/GO_0030210","source":"Gene Ontology","license":"CC BY 4.0"},"metanode":"Biological Process"},{"id":7546,"identifier":"GO:0030981","identifier_type":"str","name":"cortical microtubule cytoskeleton","properties":{"url":"http://purl.obolibrary.org/obo/GO_0030981","source":"Gene Ontology","license":"CC BY 4.0"},"metanode":"Cellular Component"},{"id":7547,"identifier":"113791","identifier_type":"int","name":"PIK3IP1","properties":{"url":"http://identifiers.org/ncbigene/113791","source":"Entrez Gene","license":"CC0 1.0","chromosome":"22","description":"phosphoinositide-3-kinase interacting protein 1"},"metanode":"Gene"},{"id":7548,"identifier":"286122","identifier_type":"int","name":"C8orf31","properties":{"url":"http://identifiers.org/ncbigene/286122","source":"Entrez Gene","license":"CC0 1.0","chromosome":"8","description":"chromosome 8 open reading frame 31"},"metanode":"Gene"},{"id":7549,"identifier":"C0877094","identifier_type":"str","name":"Application site haemorrhage","properties":{"url":"http://identifiers.org/umls/C0877094","source":"UMLS via SIDER 4.1","license":"CC BY-NC-SA 4.0"},"metanode":"Side Effect"},{"id":7550,"identifier":"PC7_6086","identifier_type":"str","name":"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","properties":{"source":"Reactome via Pathway Commons","license":"CC BY 4.0"},"metanode":"Pathway"},{"id":7551,"identifier":"144203","identifier_type":"int","name":"OVOS2","properties":{"url":"http://identifiers.org/ncbigene/144203","source":"Entrez Gene","license":"CC0 1.0","chromosome":"12","description":"ovostatin 2"},"metanode":"Gene"},{"id":7552,"identifier":"84946","identifier_type":"int","name":"LTV1","properties":{"url":"http://identifiers.org/ncbigene/84946","source":"Entrez Gene","license":"CC0 1.0","chromosome":"6","description":"LTV1 ribosome biogenesis factor"},"metanode":"Gene"},{"id":7553,"identifier":"DB06813","identifier_type":"str","name":"Pralatrexate","properties":{"url":"http://www.drugbank.ca/drugs/DB06813","inchi":"InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1","source":"DrugBank","license":"CC BY-NC 4.0","inchikey":"InChIKey=OGSBUKJUDHAQEA-WMCAAGNKSA-N"},"metanode":"Compound"},{"id":7554,"identifier":"246318","identifier_type":"int","name":"FLJ13773","properties":{"url":"http://identifiers.org/ncbigene/246318","source":"Entrez Gene","license":"CC0 1.0","chromosome":"17","description":"uncharacterized LOC246318"},"metanode":"Gene"},{"id":7555,"identifier":"134430","identifier_type":"int","name":"WDR36","properties":{"url":"http://identifiers.org/ncbigene/134430","source":"Entrez Gene","license":"CC0 1.0","chromosome":"5","description":"WD repeat domain 36"},"metanode":"Gene"},{"id":7556,"identifier":"C2062908","identifier_type":"str","name":"Gout acute","properties":{"url":"http://identifiers.org/umls/C2062908","source":"UMLS via SIDER 4.1","license":"CC BY-NC-SA 4.0"},"metanode":"Side Effect"},{"id":7557,"identifier":"6837","identifier_type":"int","name":"MED22","properties":{"url":"http://identifiers.org/ncbigene/6837","source":"Entrez Gene","license":"CC0 1.0","chromosome":"9","description":"mediator complex subunit 22"},"metanode":"Gene"},{"id":7558,"identifier":"338440","identifier_type":"int","name":"ANO9","properties":{"url":"http://identifiers.org/ncbigene/338440","source":"Entrez Gene","license":"CC0 1.0","chromosome":"11","description":"anoctamin 9"},"metanode":"Gene"},{"id":7559,"identifier":"GO:0006904","identifier_type":"str","name":"vesicle docking involved in exocytosis","properties":{"url":"http://purl.obolibrary.org/obo/GO_0006904","source":"Gene Ontology","license":"CC BY 4.0"},"metanode":"Biological Process"},{"id":7560,"identifier":"25802","identifier_type":"int","name":"LMOD1","properties":{"url":"http://identifiers.org/ncbigene/25802","source":"Entrez Gene","license":"CC0 1.0","chromosome":"1","description":"leiomodin 1 (smooth muscle)"},"metanode":"Gene"},{"id":7561,"identifier":"10160","identifier_type":"int","name":"FARP1","properties":{"url":"http://identifiers.org/ncbigene/10160","source":"Entrez Gene","license":"CC0 1.0","chromosome":"13","description":"FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)"},"metanode":"Gene"},{"id":7562,"identifier":"GO:0000150","identifier_type":"str","name":"recombinase activity","properties":{"url":"http://purl.obolibrary.org/obo/GO_0000150","source":"Gene Ontology","license":"CC BY 4.0"},"metanode":"Molecular Function"},{"id":7563,"identifier":"DB04835","identifier_type":"str","name":"Maraviroc","properties":{"url":"http://www.drugbank.ca/drugs/DB04835","inchi":"InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1","source":"DrugBank","license":"CC BY-NC 4.0","inchikey":"InChIKey=GSNHKUDZZFZSJB-HLMSNRGBSA-N"},"metanode":"Compound"},{"id":7564,"identifier":"8661","identifier_type":"int","name":"EIF3A","properties":{"url":"http://identifiers.org/ncbigene/8661","source":"Entrez Gene","license":"CC0 1.0","chromosome":"10","description":"eukaryotic translation initiation factor 3, subunit A"},"metanode":"Gene"},{"id":7565,"identifier":"GO:0043277","identifier_type":"str","name":"apoptotic cell clearance","properties":{"url":"http://purl.obolibrary.org/obo/GO_0043277","source":"Gene Ontology","license":"CC BY 4.0"},"metanode":"Biological Process"}]}